+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proton beam radiation therapy for head and neck malignancies

Proton beam radiation therapy for head and neck malignancies

Current Oncology Reports 12(3): 202-207

Proton beam radiation therapy (PBRT) has unique physical properties (e.g., Bragg Peak) that limit the amount of normal tissue irradiated in the head and neck region while maximizing the radiation delivered to the tumor. Radiation therapy is commonly used in both the primary and adjuvant setting for many head and neck malignancies. Limiting the unnecessary radiation to normal tissues within the head and neck region can result in a profound improvement in quality of life during and after treatment. Although PBRT was initially developed in the 1950s, recent technological advances have permitted the development of hospital-based facilities for proton delivery. PBRT has been shown to improve outcomes for patients with sinonasal tumors, chordomas, chondrosarcomas, ocular, and periocular malignancies. Further development of intensity-modulated proton therapy will permit comprehensive treatment for head and neck tumors.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 055259930

Download citation: RISBibTeXText

PMID: 20425080

DOI: 10.1007/s11912-010-0089-0

Related references

Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Medical Dosimetry 38(4): 390-394, 2013

Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. RadioTherapy and Oncology 118(2): 286-292, 2016

Comparison of mean radiation dose and dosimetric distribution to tooth-bearing regions of the mandible associated with proton beam radiation therapy and intensity-modulated radiation therapy for ipsilateral head and neck tumor. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 122(5): 566-571, 2016

The potential of proton beam radiation therapy in head and neck cancer. Acta Oncologica 44(8): 876-880, 2005

High-energy proton beam radiation therapy for gynecologic malignancies. Potential of proton beam as an alternative to brachytherapy. Cancer 68(1): 79-83, 1991

Proton therapy for head and neck malignancies at Tsukuba. Strahlentherapie und Onkologie 180(2): 96-101, 2004

Proton therapy for pediatric head and neck malignancies. Pediatric Blood and Cancer 65(2):, 2018

Mixed beam radiation therapy for unresectable squamous cell carcinomas of the head and neck results of a randomized radiation therapy and oncology group study. International Journal of Radiation Oncology, Biology, Physics 10(12): 2211-2216, 1984

Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. RadioTherapy and Oncology 134: 143-150, 2019

Proton Beam Radiation for Head and Neck Cancers: A Single-Institution Report on Feasibility and Early Outcomes. International Journal of Radiation Oncology*biology*physics 96(2): E377-E378, 2016

Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiation Oncology 11: 32, 2016

Proton beam radiation therapy in the treatment of pediatric central nervous system malignancies: a review of the literature. Journal of Pediatric Oncology Nursing 26(3): 142-149, 2009

Osteoradionecrosis associated with definitive radiation therapy for head and neck malignancies. Journal of Prosthetic Dentistry 49(5): 675-679, 1983

High Dose Proton Beam Therapy for Mucosal Malignant Melanoma of the Head and Neck. International Journal of Radiation Oncology*biology*physics 75(3): S700-S701, 2009

Effect of radiation therapy and chemo therapy on endocrine function in children with head and neck malignancies. Clinical Research 26(3): 302A, 1978